跳到主要內容

臺灣博碩士論文加值系統

(18.97.14.85) 您好!臺灣時間:2024/12/15 01:43
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:吳宛玲
研究生(外文):Wan-Lin Wu
論文名稱:初探鼻咽癌患者治療後之助聽器成效
論文名稱(外文):Outcome measures of hearing aid in irradiated nasopharyngeal carcinoma patients
指導教授:陳小娟陳小娟引用關係蔡森田蔡森田引用關係
指導教授(外文):Hsiao chuan ChenSen-Tien Tsai
學位類別:碩士
校院名稱:國立高雄師範大學
系所名稱:聽力學與語言治療研究所
學門:醫藥衛生學門
學類:復健醫學學類
論文種類:學術論文
論文出版年:2007
畢業學年度:95
語文別:中文
論文頁數:90
中文關鍵詞:鼻咽癌助聽器成效
外文關鍵詞:nasopharygeal carcinomaoutcome measures of hearing aid
相關次數:
  • 被引用被引用:0
  • 點閱點閱:901
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
為了探討鼻咽癌治療所造成的聽覺器官損害是否會影響鼻咽癌患者治療後助聽器介入的成效,本研究採便利取樣方式,選取有鼻咽癌病史之助聽器使用者與非鼻咽癌助聽器使用者,分別針對純音骨導聽閾、安靜及噪音下雙字詞辨識、個案導向的助聽器使用之溝通成效量表、成人聽覺表現量表-簡易版、或年長者聽覺表現量表-簡易版等四個聽覺復健成效評估向度進行分析。
本研究共分析16位助聽器使用者(鼻咽癌組與非鼻咽癌組各有8人),22隻耳朵,平均年齡為57.8歲,平均骨導聽閾值為48.7 dB HL,平均助聽器使用經驗為21.7個月,大多數患者(81%)使用全方位麥克風。結果發現:(1)鼻咽癌組之骨導聽閾年變化量(M0.5k-2kHz/low band=-0.2 dB;M4kHz/high band=2.5 dB)與非鼻咽癌組之骨導聽閾年變化量(M0.5k-2kHz/low band=-0.7 dB;M4kHz/high band=-3.4 dB),並無顯著差異。(2)不論是比較未助聽時、助聽時、或助聽前後的差異,鼻咽癌組之可接受最小訊噪比(Munaided=4.4 dB;Maided=10.0 dB;Mdiff.=5.6 dB)與非鼻咽癌組之可接受最小訊噪比(Munaided=7.5 dB;Maided=6.9 dB;Mdiff.=-0.6 dB),都無顯著差異。(3)於安靜中與1-2人對話、噪音中與1-2人對話、安靜中與群體對話、噪音中與群體對話等四種主要溝通情境,兩組之助聽器助益程度、助聽後表現、以及助聽器整體助益,都沒有顯著差異。(4)兩組之自評聽覺障礙總分,並無顯著差異。
儘管兩組在個別成效評估測驗上的表現無顯著差異,但研究暗示:(1)鼻咽癌組之周邊聽力衰退程度有高於非鼻咽癌組之周邊聽力衰退程度的傾向,(2)助聽器提供一般聽損者在噪音下的語音知覺表現改善效果有優於鼻咽癌患者的傾向。因此,建議除了加強鼻咽癌患者治療前的聽力諮詢、定期追蹤聽力外,更該考慮為鼻咽癌患者選配具有較佳噪音消減功能、方向性麥克風的助聽器,或使用調頻系統,並且訓練個體對噪音容忍度的提升、噪音下語音知覺的促進技巧。
To investigate whether the damage of auditory organs resulting from radiation therapy would affect outcome of hearing aid user, the present study sampled 8 ( 12 ears ) irradiated nasopharyngeal carcinoma patients(NPC group)and 8 ( 10 ears ) hearing impairment patients without radiation history(control group). The mean age was 57.8 years old and the mean bone-conducted threshold before hearing aid fitting was 48.7 dB HL. The mean experience of using hearing aid was 21.7 months. Participants’ performances in pure tone threshold test, words discrimination test, Client Oriented Scale of Improvement, and Hearing Handicap Inventory for Adults-short form or Hearing Handicap Inventory for the Elderly-short form, were analyzed.
Most participants(81%)chose hearing aid of omni-directional microphone. The followings were the results. (1) There was no significant difference in hearing deterioration between NPC group and control group. (2) There was no significant difference in minimal signal-to-noise ratio between NPC group and control group in any aided condition. (3) Neither in case of conversation with one or two persons in quiet or noise environment nor in case of conversation with group in quiet or noise environment showed significant difference in hearing aid benefit or aided performance between NPC group and control group. (4) There was no significant difference in handicap score between NPC group and control group.
Although no significant difference between two groups in any outcome measures was found, the present findings still implied that (1) hearing deterioration rate of NPC patients may be higher than general population. (2) NPC patients may face more difficulties in adaptation with noise environment than general population. In addition to regular hearing threshold counseling and speech training in noise environment, the choice of hearing aid with stronger noise- reduction management, directional hearing aid or FM system are recommend for irradiated NPC patients with hearing impairment.
第一章 緒論
第一節 研究背景與研究目的 .......................... 1
第二節 研究設計與研究限制 .......................... 4
第三節 研究假設與研究問題 .......................... 8
第二章 文獻探討
第一節 鼻咽癌的流行病學與臨床病理學 ................ 11
第二節 鼻咽癌治療所帶來的耳毒性副作用 .............. 16
第三節 鼻咽癌患者治療後的聽覺復健與成效評估 .. 27
第三章 研究方法
第一節 研究流程與架構 ........................ 37
第二節研究對象 .............................. 40
第三節聽覺復健成效評估 ...................... 41
第四節資料分析 .............................. 48
第四章結果與討論
第一節研究結果............................. 49
第二節討論................................. 61
第五章結論與建議 .............................. 67
參考文獻 ........................................ 69
附錄........................................... 83

表次
表2-1 放射線治療造成的耳毒性作用--動物實驗 .......... 21
表2-2 放射線治療造成的耳毒性作用--人體實驗 .......... 22
表2-3 治療鼻咽癌常用的化學藥物與副作用/影響 ......... 26
表4-1 受試者選配前背景資料 ..................... 50
表4-2 比較不同研究之助聽器棄用原因排序 ............. 61
表4-3 比較不同研究之骨導聽閾年變化量 ........... 62
表4-4 比較不同研究之五年聽損發生率 ............. 63
表4-5 比較不同研究之雙耳選配優勢 ............... 65
表4-6 聽覺復健成效的組間比較 ................... 66

圖次
圖3-1 研究流程 ................................. 39
圖4-1 受試者選配前各頻率骨導聽閾 ............... 51
圖4-2 受試者各頻率骨導聽閾年變化量 ............. 53
圖4-3 受試者裸耳最舒適位階、
裸耳最大可忍受噪音位階 ............ 54
圖4-4 受試者助聽後最舒適位階、
助聽後最大可忍受噪音位階 ........... 56
圖4-5 受試者助聽前後可接受之最小訊噪比 ......... 57
圖4-6 受試者於四種主要溝通情境下的
         助聽器助益分數 .... 58
圖4-7 受試者於四種主要溝通情境下的
         助聽表現 ......... 60

附錄
附錄一 個案背景資料調查表 ....................... 83
附錄二 個案聽力追蹤表 ........................... 84
附錄三 受試者同意書 ............................. 85
附錄四 個案導向的助聽器使用之溝通成效量表 ......... 87
附錄五 成人聽覺表現簡易量表 ........................88
附錄六 年長者聽覺表現簡易量表 .......................89
附錄七 雙字詞辨識測驗詞彙表 ..................... 90
一、中文部分
方良金,柯昌輝(1971):鼻咽癌。耳鼻喉科醫學會雜誌,6(2),129-131。
王滿堂(2002):台灣人的光榮。2005年11月17日,取自
http://www.kfsyscc.org/index.php?article_id=677&articleid_page=1
王智弘(2004):放射治療與中耳炎。台灣耳鼻喉頭頸外科雜誌,39(1),52-55。
台灣嬰幼兒聽力網(軼年):各國嬰兒聽力醫學報告。2005年9月20日,取自
http://www.bhp.doh.gov.tw/child_listening/allhtm/g.htm
行政院衛生署國民健康局(2005):民國九十一年癌症登記報告。2005年11月20日,取自http://www.bhp.doh.gov.tw:8080/BHP/fileviewer?id=256282
沈宗憲,林大潔,陳建銓,徐茂銘(1990):鼻咽癌病人放射線治療中之耳咽管功能評估。耳鼻喉科醫學會雜誌,25(4),307-311。
吳俊良(2004):積液性中耳炎的處理流程。台灣耳鼻喉頭頸外科雜誌,39(1),17-20。

林鴻清(1998):臨床聽力學。未出版手稿,私立中山醫學大學聽力與語言治療學系。
林滄雄(1998):耳鼻喉科秘笈。台北:合記。
林進清(2000):以分子生物學方法偵測鼻咽癌遠處轉移及臨床治療改進之研究。國立陽明大學臨床醫學研究所博士論文。全國博碩士論文資訊網,89YM000521005。

和信治癌中心醫院(2001):征服頭頸癌。台北:天下生活。
林敬原(2004):淺談鼻咽部位的解剖構造及功能。2005年11月20日,取自http://www.kfsyscc.org/index.php?article_id=1012
柯政郁(2001):鼻咽癌的基因異常。國立台灣大學臨床醫學研究所博士論文。全國博碩士論文資訊網,90NTU01521003。

柯政郁(軼年):鼻咽癌的防制。2005年11月20日,取自
http://w3.mc.ntu.edu.tw/department/ent/ko/ko-2.
html
徐茂銘(1992):鼻咽癌的治療。載於徐茂銘、蕭自佑、劉殿楨(主編),當代耳鼻喉科之臨床(163-174頁)。財團法人杜詩綿教授學術基金會。
庫克,麥克勞夫,金傑利(2001):癌症放射線治療(黃愷瑜譯)。台北:原水文化。

陳小娟(2005):聽能復健。未出版手稿,國立高雄師範大學聽力與語言治療研究所。
陳秋芬(2006):使用者對助聽器之音效抱怨及其與助聽器不滿意度之關係。國立高雄師範大學聽力學與語言治療研究所碩士論文。全國博碩士論文資訊網,094NKNU0748009。

張燕良,徐茂銘,謝地(1993):鼻咽癌在台灣。行政院衛生署八十二年度委託研究計畫研究報告(DOH)。台灣醫學會。
張斌(1998):耳鼻喉科學。台北:正中。
國家衛生研究院癌症研究組(2000):鼻咽癌之診斷與治療共識(ISBN:957-02-6326-1)。台北:國家衛生研究院。
郭宜霖(2000):強度調控放射治療與傳統放射治療技術對鼻咽癌之成效比較。國立清華大學原子科學系碩士論文。全國博碩士論文資訊網,89NTHU0257021。
梁家光(2004):中耳炎的診斷。台灣耳鼻喉頭頸外科雜誌,39(1),10。
黃真萍(2004):華人的特產-鼻咽癌。2005年11月22日,取自
http://www.kfsyscc.org/index.php?article_id=100
8
楊怡和(1988):耳鼻喉科之臨床手冊。台北:合記。
楊宗翰,許志宏,林清榮(1998):鼻咽癌治療後復發的臨床症狀。耳鼻喉科醫學會雜誌,33(2),113-117。
楊義良(1999):聽力科學。未出版手稿,私立中山醫學大學聽力與語言治療學系。
鄧育欣(2002):台灣地區鼻咽癌之家族研究—累積發生危險性和危險因子。國立台灣大學流行病學研究所碩士論文。全國博碩士論文資訊網,91NTU01544021。

鄭春鴻(2004):癌症治療的新進展。2005年11月12日,取自http://www.kfsyscc.org/index.php?article_id=1107
鄭如惠(2006):助聽器滿意度與不再使用助聽器的原因。國立高雄師範大學聽力學與語言治療研究所碩士論文。全國博碩士論文資訊網,094NKNU0748007。

謝政毅(2004);鼻咽癌與化學治療。2005年11月12日,取自http://www.kfsyscc.org/index.php?article_id=1013
閻愷正(2005):鼻咽癌的手術治療。2005年11月12日,取自http://www.kfsyscc.org/index.php?article_id=2330
蘇志英,林義峰,阮愷輝(1984):鼻咽癌的耳症候學。耳鼻喉科醫學會雜誌,19(1),32-37。
二、西文部分
Abrams H.B.(2000). Outcome Measures in Audiology: Knowing We've Made a Difference. Abstract retrieved September 18 2005, from http://www.audiologyonline.com/articles/arc_disp.asp?article_id=236
American Speech-Language-Hearing Association(2005). Causes of Hearing Loss in Adults. Abstract retrieved September 18 2005, from http://www.asha.org/public/hearing/disorders/causes_adults.htm
Bohne B.A., Marks J.E., Glasgow G.P.(1985). Delayed effects of ionizing radiation on the ear. Laryngoscope,95,818-828.
Byrne D., Noble W., LePage B.(1992). Effects of long-term bilateral and unilateral fitting of different hearing aid types on the ability to locate sounds. Journal of American Academy of Audiology,3(6),369-82.
Bentler R.A., Niebuhr D.P., Getta J.P., Anderson C.V.(1993). Longitudinal study of hearing aid effectiveness. Ⅰ:Objective measures. Journal of Speech and Hearing Research,36,808-819.
Cox R.M., Alexander G.C.(1992). Maturation of hearing aid benefit:subjective and objective measurements. Ear and Hearing,13(3),131-141.
Chmiel R., Jerger J.(1993). Some factors affecting assessment of handicap in the elderly. Journal of American Academy of Audiology,4,249-257.
Chang S.D., Poen J., Hancock S.L.(1998). Acute hearing loss following fractionated stereotactic radiosurgery for acoustic neuroma:report of two cases. Journal of Neurosurgery,89,321-325.
Cheng P.W., Young Y.H., Lou P.J.(1999). Patolous Eustachian tube in long-term survivors of nasopharyngeal carcinoma. Annals of Otology, Rhinology and Laryngology,108,201-204.
Cook K.A., Walsh M.(2005). Otitis media. Abstract retrieved September 18 2005, from http://www.emedicine.com/EMERG/topic351.htm
Dillon H., James A., Ginis J.(1997). Client Oriented Scale of Improvement(COSI)and its relationship to several other measurements of benefit and satisfaction provided by hearing aids. Journal of American Academy of Audiology,8(1),27-43.
Dillon H.(2001). Hearing aids. New York:Thieme.
DeBonis D.A., Donohue C.L.(2004). Survey of audiology – fundamentals for audiologists and health professionals, 113-117;160-164. U.S.A.:Pearson Education Inc.
Fang, F.M., Chiu, H.C., Kuo, W.R., Wang, C.J., Leung, S.W., Chen, H.C., Sun, L.M., Hsu, H.C.(2002). Health-related quality of life for nasopharyngeal carcinoma patients with cancer-free survival after treatment. International Journal of Radiation Oncology Biology Physics,53(4),959–968.
Freyaldenhoven M.C., Plyler P.N., Thelin J.W., Burchfield S.B.(2006). Acceptance of noise with monaural and binaural amplification. Journal of American Academic Audiology,17,659-666.
Gatehouse(1997). Outcome measures for the evaluation of adult hearing aid fitting and services:scientific and technical report. London:Department of Health.
Gibb A.G., Loh K.S(2000). The role of radiation in delayed hearing loss in nasopharyngeal carcinoma. Journal of Laryngology and Otology,14,39-144.
Horwitz A.R., Turner C.W.(1997). The time course of hearing aid benefit. Ear and Hearing,18(1),1-11.
Ho W.K., Wei W.I., Kwong D.L.(1999). Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma:a prospective study. Head Neck,21,547-553.
Hain T.C.(2001). Congenital deafness. Abstract retrieved September 18 2005, from http://www.american-hearing.org/name/cong_hearing.html
Honore H.B., Bentzen S.M., Moller K., Grau C.(2002). Sensorineural hearing loss after radiotherapy for nasopharyngeal carcinoma:individualized risk estimation. Radiotherapy and Oncology,65,9-16.
Humes L.E., Wilson D.L., Barlow N.N., Garner C.(2002). Changes in hearing-aid benefit following 1 or 2 years of hearing-aid use by older adults. Journal of Speech, Language, and Hearing Research,45, 772-782.
Jereczek-Fossa B.A., Zarowski A., Milani F., Orecchia R.(2003). Radiotherapy-induced ear toxicity. Cancer Treatment Reviews,29,417-430.
Ko J.Y., Hsieh T.(1988). Investigation of life quality in nasopharyngeal carcinoma patients with long-term Survival after radiotherapy. Journal of Otolaryngology,23,181-190.
Kwong D.L.W., Wei W.I., Sham J.S.T., Ho W.K., Yuen P.W., Au D.K.K., Wu P.M., Choy D.T.K.(1996). Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma:a prospective study of the effect of radiation and cisplatin treatment. International Journal of Radiation Oncology Biology Physics,36(2),281-289.
Killion, M. C. (1997). SNR loss:“I can hear what people say, but I can’t understand them.” The Hearing Review,4(12), 8–14.
Kochkin S.(2000) MarkeTrak V: “Why my hearing aids are in the drawer”: The consumers’ perspective. Hearing Journal Review,53(2),34–42.
Kricos P.B.(2006). Minimizing the effects of non-audiological variables on hearing aid outcomes. Abstract retrieved May 31 2006, from http://www.audiologyonline.com/articles/article_detail.asp?article_id=1527
Leach W.(1965). Irradiation of the ear. Journal of Laryngology and Otology,79,870-880.
Lau S.K., Wei W.I., Sham J.S.T., Choy D.T.K., Hui Y.(1992). Early changes of auditory brain stem evoked response after radiotherapy for nasopharyngeal carcinoma – A prospective study. Journal of Laryngology and Otology,106,887-892.
Licitra L., Bernier J., Cvitkovic E., Grandi C., Spinazze S., Bruzzi P., Gatta G., Molinari P.(2003). Cancer of the nasopharynx. Critical Reviews in Oncology and Hematology,45,199-214.

Liu M.T., Hsieh C.Y., Chang T.H., Lin J.P., Huang C.C., Wang A.Y.(2003). Prognostic Factors Affecting the Outcome of Nasopharyngeal Carcinoma. Japan Journal of Clinical Oncology,33(10),501–508.
Mulrow C.D., Tuley M.R., Aguilar C.(1992). Sustained benefits of hearing aids. Journal of Speech and Hearing Research,35,1402-1405.
Muller H.G., Weber J., Hornsby B.W.Y.(2006). The effects of digital noise reduction on the acceptance of background noise. Trends in Amplification,10(2),83-93.
Nabelek, A. K., Tucker, F. M., Letowski, T. R.(1991). Toleration of background noises: Relationship with patterns of hearing aid use by elderly persons. Journal of Speech and Hearing Research,34,679–685.
Noble W., Ter-Horst K., Byrne D.(1995). Disabilities and handicaps associated with impaired auditory localization. Journal of American Academy of Audiology, 6(2), 129-140.
Noble W.(1998). Self-assessment of hearing and related functions. British:Whurr Publishers Ltd.
Nabelek, A. K., Burchfield, S. B., Webster, J. D.(2003). Relationship between acceptance of background noise and hearing aid use. Journal of the Acoustical Society of America,113,2289.
Nabelek A.K., Tampas J.W., Burchfield S.B.(2004).
Comparison of Speech Perception in Background Noise With Acceptance of Background Noise in Aided and Unaided Conditions. Journal of Speech, Language, and Hearing Research,47,1001–1011.
Nabelek A.K.(2005). Acceptance of background noise may be key to successful fittings. The Hearing Journal,58(4),10-15.
National Cancer Institute(2005). Nasopharyngeal cancer. Abstract retrieved December 28 2005, from https://www.meb.uni-bonn.de/cancer.gov/CDR0000062918.html
Oh Y.T., Kim C.H., Choi J.H., Kang S.H., Chun M.(2004). Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma. Radiotherapy and Oncology,72,79-82.
Popelka M.M., Cruickshanks K.J., Wiley T.L., Tweed T.S., Klein B.E., Klein R.(1998). Low prevalence of hearing aid use among older adults with hearing loss: the Epidemiology of Hearing Loss Study. Journal of the American Geriatrics Society,46(9),1075-1078.
Raaijmakers E., Engelen A.M.(2002). Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation? A systematic review of the literature. Radiotherapy and Oncology,65,1-7.
Schell M.J., McHaney V.A., Green A.A., Kun L.E., Hayes F.A., Horowitz M., Meyer W.H.(1989). Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. Journal of Clinical Oncology,7, 754-760.
Swan I.R.C., Gatehouse S.(1990). Factors influencing consultation for management of hearing disability. British Journal of Audiology,24(3),155-160.
Stataloff R.T., Rosen D.C.(1994). Effects of cranial irradiation on hearing acuity:a review of the literature. American Journal of Otology,15(6), 772-779.
Surr R.K., Cord M.T., Walden B.E.(1998). Long-term versus short-term hearing aid benefit. Journal of American Academy of Audiology,9(3),165-171.
Silva J.J., Tsang R.W., Panzarella T.(2000). Results of radiotherapy for epithelial skin cancer of the pinna:the Princess Margaret Hospital experience,1982-1993. International Journal of Radiation Oncology Biology Physics,47,451-459.
Spano J.P., Busson P., Atlan D., Bourhis J., Pignon J.P., Esteban C., Armand J.P.(2003). Nasopharyngeal carcinomas: an update. European Journal of Cancer,39,2121–2135.

Sanguineti G., Bossi P., Pou A., Licitra L.(2003). Timing chemo-radiotherapy and patient selection for locally advanced nasopharyngeal carcinoma. Clinical Oncology,5,451–460.
Skinner R.(2004). Best practice in assessing ototoxicity in children with cancer. European Journal of Cancer,40,2352-2354.
Segar A.(2006). Personality type and self-perception of hearing aid benefit. Abstract retrieved January 4 2007, from https://drum.umd.edu/dspace/bitstream/1903/3739/1/umi-umd-3566.pdf
Taylor K.(1993). Self-perceived and audiometric evaluations of hearing aid benefit in the elderly. Ear and Hearing,14(6),390-394.
Tye-Murray N.(1998). Foundations of aural rehabilitation. London:Singular Publishing Group.
Tsukasaki N., Whitworth C.A., Rybak L.P.(2000). Acute changes in cochlear potentials due to cisplatin. Hearing Research,149,189-198.
Teo P.M.L., Chan A.T.C.(2002). Treatment strategy and clinical experience. Seminars in Cancer Biology, 2,497–504.
Weinstein B.E., Spitzer J.B., Ventry I.M. (1986). Test-retest reliability of the Hearing Handicap Inventory for the Elderly. Ear and Hearing,7(5),295-299.
Weinstein B.E.(2000). Outcome measures in rehabilitative audiology. In Alpiner J.G., McCarthy P.A.(Eds.), Rehabilitative audiology:children and adults (575-593). New York:Lippincott Williams & Wilkins.
Wang L.F., Kuo W.R., Ho K.Y., Lee K.W., Lin C.S.(2004). A long-term study on hearing status in patients with nasopharyngeal carcinoma after radiotherapy. Otology & Neurotology,25(2),168-173.
Wei W.I., Sham S.T.(2005). Nasopharyngeal carcinoma. Lancet,365,2041–2054.
Yeh S.A., Tang Y. Lui C.C., Huang Y.J., Huang E.Y.(2005). Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. International Journal of Radiation Oncology Biology Physics,62(3), 672–679.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top